Tag: gallium Ga 68 gozetotide

Home / gallium Ga 68 gozetotide

Categories

Pluvicto is approved by FDA for metastatic castration-resistant prostate cancer

April 2022: The Food and Drug Administration approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan, Advanced Accelerator Applications USA, Inc., a Novartis company) for the treatment of adult patie...
gallium-ga-68-gozetotide

Scan the code